A brief overview of Cognitive and Memory Enhancer Drugs Market is provided in the report based on product scope and market status & outlook.
Portland, OR -- (SBWIRE) -- 06/25/2018 -- Cognitive enhancers are drugs and supplements, which are majorly used by patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging. In addition, these drugs are used by health individuals to improve cognitive functions such as memory, intelligence, motivation, stamina, alertness attention, and concentration.
Get Sample@ https://www.researchbeam.com/cognitive-and-memory-enhancer-drugs-market/request-sample
The global cognitive and memory enhancer drugs market was valued at $3,680 million in 2016, and is projected to reach $6,598 million by 2023, growing at a CAGR of 8.6% from 2017 to 2023. The growth of the global cognitive and memory enhancer drugs market is driven by surge in geriatric population and rise in prevalence of neurological & memory-related disorders. Furthermore, the benefits offered by cognitive drugs such as improved memory and reasoning fuel the market growth. However, ethical issues related to the use of these drugs impede the market growth.
The global cognitive and memory enhancer drugs market is segmented on the basis of product, application, and region. Based on product, the market is categorized into Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall, and others. The applications covered in the study include disease treatment, academic performance, athletic performance, and others. Disease treatment segment is further bifurcated into developmental conditions and neurodegenerative disease. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides an extensive analysis of the current and emerging trends and dynamics in the global cognitive and memory enhancer drugs market.
This study provides the competitive landscape of the global market to predict the competitive environment across geographies.
This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
Region- and country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
Get 15% Discount on this Report@ https://www.researchbeam.com/cognitive-and-memory-enhancer-drugs-market/purchase-enquiry
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
The key players profiled in this report are as follows:
Eisai Co., Ltd.
Johnson & Johnson
Takeda Pharmaceutical Company Limited
Cephalon, Inc. (Teva Pharmaceutical Industries Ltd.)
Check Full Report with TOC@ https://www.researchbeam.com/cognitive-and-memory-enhancer-drugs-market
About Research Beam
Research Beam's uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim. With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
phone+1 (800) 910-6452